Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study [0.03%]
转移性膀胱癌的现实世界治疗方案及总生存期：STATEG-Bladder研究
Fabien Moinard-Butot,Jean-Baptiste Barbe-Richaud,Edwige Baudry et al.
Fabien Moinard-Butot et al.
Background and purpose: The treatment landscape for metastatic urothelial carcinoma (mUC) has rapidly evolved with immune checkpoint inhibitors (ICI), FGFR-targeted therapies, antibody-drug conjugates, and more recently f...
Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study [0.03%]
免疫肿瘤和血管内皮生长因子受体靶向治疗后转移性肾细胞癌患者的真实世界治疗模式及临床结局：基于社区癌症中心的多中心研究
Neil J Shah,Sneha Sura,Reshma Shinde et al.
Neil J Shah et al.
Background: First-line immune-oncology (IO) agents and VEGF-targeted tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) have complicated subsequent treatment decisions. This study describes real-...
Combined and individual effects of neoadjuvant chemotherapy and lymph node dissection on survival in non-muscle-invasive bladder cancer undergoing radical cystectomy [0.03%]
新辅助化疗和淋巴结清扫对行根治性膀胱切除术的非肌层浸润性膀胱癌患者生存的影响：综合分析及个体分析
Yiyu Sheng,Longlong Fan,Sikun Zhu et al.
Yiyu Sheng et al.
Background: The roles of neoadjuvant chemotherapy (NAC) and lymph node dissection (LND), particularly their combined use, remain unclear in patients with non-muscle-invasive bladder cancer (NMIBC) undergoing radical cyste...
Spatial immunophenotyping of tumor-associated macrophages predicts prognostic outcomes in clear cell renal cell carcinoma [0.03%]
肿瘤相关巨噬细胞的空间免疫分型可预测透明细胞肾细胞癌的预后
Jisu Uh,Jisup Kim,Su-Jin Shin et al.
Jisu Uh et al.
Introduction: Clear cell renal cell carcinoma (ccRCC), the most common kidney cancer subtype, has high rates of metastasis and recurrence. Its tumor microenvironment (TME), particularly tumor-associated macrophages (TAMs)...
Samuel Ruder,Pardis Ziaeefar,Ambika P Jaswal et al.
Samuel Ruder et al.
This review highlights recent data regarding antigens on the cell surface of prostate cancer cells or cells in the prostate cancer tumor microenvironment which may serve as targets for novel therapeutics. Emphasis is placed on clinical data...
Corrigendum to Deciphering the role of zingiber officinale phytochemicals for the treatment of prostate cancer: Interactions of phytochemicals with androgen receptor prostate cancer mutant H874Y ligand binding domain, Urologic oncology: Seminars and original investigations 43 (2025) 711.e9-711.e27 [0.03%]
姜黄素化合物治疗前列腺癌的作用解读：姜黄素与雄激素受体前列腺癌突变H874Y配体结合域的相互作用（乌罗洛尼亚： seminar and original investigations卷43 (2025) 711.e9-711.e27）勘误项
Guanghui Lei,Shuai Yan,Xu Gao et al.
Guanghui Lei et al.
Published Erratum
Urologic oncology. 2026 Feb 24:111003. DOI:10.1016/j.urolonc.2026.111003 2026
The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review [0.03%]
肿瘤微环境在阴茎癌中的作用及新兴治疗概念：综述文章
August Fiegl,Jan Mink,Kerstin Junker et al.
August Fiegl et al.
Penile carcinoma (PC) is a rare malignancy with substantial geographic and etiological heterogeneity. Histologically, it is stratified into HPV-associated and HPV-independent subtypes, each with distinct clinical behaviors and molecular fea...
Comparison between cutaneous ureterostomy and the ileal conduit in patients with urothelial bladder carcinoma undergoing radical cystectomy: Expanding eligibility for the gold standard treatment [0.03%]
与回肠导管术相比，皮肤尿道术后尿流改道患者的生活质量提高：扩大金标准治疗的适用范围
Renato Meirelles Mariano da Costa Jr,Lucas Antonio Pereira do Nascimento,Tiago Aparecido Silva et al.
Renato Meirelles Mariano da Costa Jr et al.
Objective: To compare outcomes of cutaneous ureterostomy (CU) and ileal conduit (IC) after radical cystectomy (RC), evaluating whether CU may expand surgical eligibility for frail patients with bladder cancer. ...
Association of denosumab treatment with survival and skeletal-related events in Asian men with mCRPC: A real-world observational study [0.03%]
亚洲mCRPC男性患者中地诺单抗治疗与生存和骨骼相关事件的关系：一项真实世界观察性研究
Chien-Chang Kao,En Meng,Tai-Lung Cha et al.
Chien-Chang Kao et al.
Background: To identify the effect of denosumab treatment on survival outcomes and skeletal related events (SREs) in Asian patients with castration-resistant prostate cancer (mCRPC). ...